Exzeo CEO buys 2,000 shares in open market
Exzeo Group, Inc. director and Chief Executive Officer Paresh Patel reported an open-market purchase of 2,000 shares of common stock at $14.81 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exzeo Group, Inc. director and Chief Executive Officer Paresh Patel reported an open-market purchase of 2,000 shares of common stock at $14.81 per share. Following this transaction, he directly owns 1,586,013 common shares. The filing also lists a stock option to buy 5,000,000 common shares at an exercise price of $23.00 per share, expiring on October 1, 2031. According to the disclosure, this option was granted on October 1, 2021 and vests over time, with one fourth vesting on October 1, 2022 and additional portions vesting on each January 1, April 1, July 1 and October 1 thereafter.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,000 | $14.81 | $30K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- F1. On October 1, 2021, the reporting person was granted an option to purchase 5,000,000 shares of common stock. The option vested with respect to one fourth of the shares on October 1, 2022 and with respect to one sixteenth of the shares on each January 1, April 1, July 1 and October 1 thereafter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Exzeo Group (XZO) CEO Paresh Patel report?
What stock options for Exzeo Group (XZO) are disclosed for Paresh Patel?
How does Paresh Patel’s Exzeo Group (XZO) option vest according to the disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.